Skip to Content

Waters Corp WAT

Morningstar Rating
$351.11 +14.69 (4.37%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

WAT is trading at a 125% premium.
Price
$336.42
Fair Value
$329.00
Uncertainty
Medium
1-Star Price
$831.97
5-Star Price
$546.40
Economic Moat
Mfct
Capital Allocation
Wpktsfqd

Bulls Say, Bears Say

Bulls

Waters' analytical instruments remain the gold standard in several applications, especially LC-MS for biopharmaceutical firms, where regulations preserve consistent recurring sales for many years.

Bears

Waters remains an extremely focused organization, which creates the potential for cash flow variability if its products fall out of favor.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if WAT is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$336.42
Day Range
$338.69352.12
52-Week Range
$231.90363.80
Bid/Ask
$139.54 / $353.72
Market Cap
$20.83 Bil
Volume/Avg
791,251 / 420,482

Key Statistics

Price/Earnings (Normalized)
28.63
Price/Sales
6.86
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
0.07%

Company Profile

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2023, Waters generated 57% from biopharmaceutical customers, 31% from industrial clients, and 12% from academic/government institutions.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Mid Core
Total Number of Employees
7,900

Competitors

Valuation

Metric
WAT
TMO
DHR
Price/Earnings (Normalized)
28.6326.7330.88
Price/Book Value
15.884.853.46
Price/Sales
6.865.268.27
Price/Cash Flow
24.1825.7828.14
Price/Earnings
WAT
TMO
DHR

Financial Strength

Metric
WAT
TMO
DHR
Quick Ratio
1.391.191.34
Current Ratio
2.221.701.85
Interest Coverage
8.284.8315.85
Quick Ratio
WAT
TMO
DHR

Profitability

Metric
WAT
TMO
DHR
Return on Assets (Normalized)
17.19%8.69%5.15%
Return on Equity (Normalized)
88.59%18.71%8.40%
Return on Invested Capital (Normalized)
25.75%10.97%6.02%
Return on Assets
WAT
TMO
DHR
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncZqkwqmdsLgs$220.6 Bil
DHR
Danaher CorpQcchydwwQwpfpq$184.8 Bil
A
Agilent Technologies IncQwvjtdhvbKmtgc$43.9 Bil
IQV
IQVIA Holdings IncYvjjcpqqCsycr$42.6 Bil
IDXX
IDEXX Laboratories IncCfqcsrsrGkysrc$42.1 Bil
MTD
Mettler-Toledo International IncWjrwztjhrFkhvrw$32.3 Bil
ICLR
Icon PLCJjyrcvgVgwgr$26.1 Bil
ILMN
Illumina IncKtqtwljlBzvchc$17.6 Bil
LH
Laboratory Corp of America HoldingsFjbgcfgglVqwqqc$17.4 Bil

Sponsor Center